Xiaoran Zhang
Research Subjects
Xiaoran Zhang has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Derek A. Haas
Avant-garde Health, Boston, Massachusetts
8 shared publications - Joseph A. Abboud
Division of Shoulder and Elbow Surgery, Rothman Orthopaedics, Philadelphia, USA
8 shared publications - Catherine J. Fedorka
Cooper Medical School of Rowan University, Camden, NJ, USA; Department of Orthopaedic Surgery, Cooper University Health Care, Camden, NJ, USA
7 shared publications - Jason E. Simon
Department of Orthopaedic Surgery, Massachusetts General Hospital/Newton-Wellesley Hospital, Boston, MA, USA
7 shared publications - Jon J. P. Warner
Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, MA, USA
7 shared publications - Adam Z. Khan
Southern California Permanente Medical Group, Kaiser Permanente, Panaroma city, USA
6 shared publications
Latest Publications
- 27 July 2026
- Published by Wolters Kluwer Health in Retina
Surgeon Volume and Success Rate in Primary Rhegmatogenous Retinal Detachment
Purpose: Evaluate the incidence and predictors of primary rhegmatogenous retinal detachment (RD) revision among Medicare beneficiaries. Methods: We included adult patients undergoing RD repair using scleral buckle and/or vitrectomy. We extracted patient demographics and information pertaining to the RD (using ICD-10 modifiers) and surgical repair (using CPT codes). Surgeon-level factors included the surgeon volume of RD in the dataset, surgeon graduation year, practice volume and setting (teaching vs not and urban vs rural). Surgeon volume was categorized as: 10-25 surgeries, 26-50 surgeries and > 50 surgeries. RD revision was defined as repeat surgery or pneumatic retinopexy in the same eye within 2 years. Results: 25,456 surgeries were included. Average age was 70.4 ± 8.3 and 9,105 (35.8%) were female. Revision was needed in 3,649 (14.3%). The median time to RD revision was 73 days. The main predictors of RD revision were GRT (RR=1.39; 95% CI=1.13–1.72), total RD (RR=1.30; 95% CI=1.15–1.47), and complex vitrectomy +/- buckle (RR=1.29; 95% CI=1.09–1.53). Conclusions: RD revision was needed in 14.3%. The main factors associated with increased risk of RD revision were the need for complex vitrectomy, GRT and total RD. Surgeon and practice volumes were not significant predictors.
- 27 July 2026
- Published by Wolters Kluwer Health in Retina
Surgeon Volume and Success Rate in Primary Rhegmatogenous Retinal Detachment
Purpose: Evaluate the incidence and predictors of primary rhegmatogenous retinal detachment (RD) revision among Medicare beneficiaries. Methods: We included adult patients undergoing RD repair using scleral buckle and/or vitrectomy. We extracted patient demographics and information pertaining to the RD (using ICD-10 modifiers) and surgical repair (using CPT codes). Surgeon-level factors included the surgeon volume of RD in the dataset, surgeon graduation year, practice volume and setting (teaching vs not and urban vs rural). Surgeon volume was categorized as: 10-25 surgeries, 26-50 surgeries and > 50 surgeries. RD revision was defined as repeat surgery or pneumatic retinopexy in the same eye within 2 years. Results: 25,456 surgeries were included. Average age was 70.4 ± 8.3 and 9,105 (35.8%) were female. Revision was needed in 3,649 (14.3%). The median time to RD revision was 73 days. The main predictors of RD revision were GRT (RR=1.39; 95% CI=1.13–1.72), total RD (RR=1.30; 95% CI=1.15–1.47), and complex vitrectomy +/- buckle (RR=1.29; 95% CI=1.09–1.53). Conclusions: RD revision was needed in 14.3%. The main factors associated with increased risk of RD revision were the need for complex vitrectomy, GRT and total RD. Surgeon and practice volumes were not significant predictors.
- Open Access
- 2 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1900
Examining the Relationship Between Academic Excellence and Clinical Productivity in Orthopedic Surgery
Background/Objectives: The relationship between clinical volume and academic performance in orthopedic surgery remains understudied. The purpose of this study is to explore the characteristics of high-achieving academic orthopedic surgeons in an attempt to extrapolate patterns and trends that govern the relationship between clinical performance and academia in orthopedic surgery. Methods: The 2023 National Plan and Provider Enumeration System and Medicare claims data (2021–2022) databases were used to include all active orthopedic surgeons of different subspecialties. A publication score, based on publication volume, journal impact, and authorship position, was calculated for each included surgeon, and surgeons who scored in the top 5% were deemed high-achieving academic orthopedic surgeons. Additional data pertaining to demographic characteristics, clinical volume, relative value units (RVUs), and Healthgrades ratings were recorded and analyzed. Results: A total of 23,403 orthopedic surgeons were included in our study, with 1169 considered top researchers. There were significant disparities in multiple parameters according to gender. Moreover, there were geographic variations among orthopedic surgeons with regard to mean publication scores, clinical volume, and RVUs. The top researcher cohort had a higher mean publication score (p < 0.001) and a higher mean clinical volume (p < 0.001) when compared to the total surgeon cohort. Mean RVUs were higher in the total surgeon cohort, although not reaching significance. Hip and knee, as well as shoulder and elbow surgeons, had significantly greater clinical volumes in the top researcher cohort than in the total surgeon cohort (p < 0.001). Despite differences in clinical and research metrics, there were no significant differences in mean Healthgrades ratings and the mean number of Healthgrades ratings between the top researcher sample and the non-top researcher sample. Conclusions: Higher research productivity was not associated with lower clinical productivity, as high-achieving academic orthopedic surgeons demonstrated high academic performance while remaining clinically active.
- 2 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (5) , 1900
Open AccessExamining the Relationship Between Academic Excellence and Clinical Productivity in Orthopedic Surgery
Background/Objectives: The relationship between clinical volume and academic performance in orthopedic surgery remains understudied. The purpose of this study is to explore the characteristics of high-achieving academic orthopedic surgeons in an attempt to extrapolate patterns and trends that govern the relationship between clinical performance and academia in orthopedic surgery. Methods: The 2023 National Plan and Provider Enumeration System and Medicare claims data (2021–2022) databases were used to include all active orthopedic surgeons of different subspecialties. A publication score, based on publication volume, journal impact, and authorship position, was calculated for each included surgeon, and surgeons who scored in the top 5% were deemed high-achieving academic orthopedic surgeons. Additional data pertaining to demographic characteristics, clinical volume, relative value units (RVUs), and Healthgrades ratings were recorded and analyzed. Results: A total of 23,403 orthopedic surgeons were included in our study, with 1169 considered top researchers. There were significant disparities in multiple parameters according to gender. Moreover, there were geographic variations among orthopedic surgeons with regard to mean publication scores, clinical volume, and RVUs. The top researcher cohort had a higher mean publication score (p < 0.001) and a higher mean clinical volume (p < 0.001) when compared to the total surgeon cohort. Mean RVUs were higher in the total surgeon cohort, although not reaching significance. Hip and knee, as well as shoulder and elbow surgeons, had significantly greater clinical volumes in the top researcher cohort than in the total surgeon cohort (p < 0.001). Despite differences in clinical and research metrics, there were no significant differences in mean Healthgrades ratings and the mean number of Healthgrades ratings between the top researcher sample and the non-top researcher sample. Conclusions: Higher research productivity was not associated with lower clinical productivity, as high-achieving academic orthopedic surgeons demonstrated high academic performance while remaining clinically active.
- 20 November 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (1) , 9-15
Defining the Cost of Arthroscopic Rotator Cuff Repair
Background: Rotator cuff repair (RCR) is a frequently performed outpatient orthopaedic surgery, with substantial financial implications for health-care systems. Time-driven activity-based costing (TDABC) is a method for nuanced cost analysis and is a valuable tool for strategic health-care decision-making. The aim of this study was to apply the TDABC methodology to RCR procedures to identify specific avenues to optimize cost-efficiency within the health-care system in 2 critical areas: (1) the reduction of variability in the episode duration, and (2) the standardization of suture anchor acquisition costs. Methods: Using a multicenter, retrospective design, this study incorporates data from all patients who underwent an RCR surgical procedure at 1 of 4 academic tertiary health systems across the United States. Data were extracted from Avant-Garde Health’s Care Measurement platform and were analyzed utilizing TDABC methodology. Cost analysis was performed using 2 primary metrics: the opportunity costs arising from a possible reduction in episode duration variability, and the potential monetary savings achievable through the standardization of suture anchor costs. Results: In this study, 921 RCR cases performed at 4 institutions had a mean episode duration cost of $4,094 ± $1,850. There was a significant threefold cost variability between the 10th percentile ($2,282) and the 90th percentile ($6,833) (p < 0.01). The mean episode duration was registered at 7.1 hours. The largest variability in the episode duration was time spent in the post-acute care unit and the ward after the surgical procedure. By reducing the episode duration variability, it was estimated that up to 640 care-hours could be saved annually at a single hospital. Likewise, standardizing suture anchor acquisition costs could generate direct savings totaling $217,440 across the hospitals. Conclusions: This multicenter study offers valuable insights into RCR cost as a function of care pathways and suture anchor cost. It outlines avenues for achieving cost-savings and operational efficiency. These findings can serve as a foundational basis for developing health-economics models. Level of Evidence: Economic and Decision Analysis Level III. See Instructions for Authors for a complete description of levels of evidence.
- 20 November 2024
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 107 (1) , 9-15
Defining the Cost of Arthroscopic Rotator Cuff Repair
Background: Rotator cuff repair (RCR) is a frequently performed outpatient orthopaedic surgery, with substantial financial implications for health-care systems. Time-driven activity-based costing (TDABC) is a method for nuanced cost analysis and is a valuable tool for strategic health-care decision-making. The aim of this study was to apply the TDABC methodology to RCR procedures to identify specific avenues to optimize cost-efficiency within the health-care system in 2 critical areas: (1) the reduction of variability in the episode duration, and (2) the standardization of suture anchor acquisition costs. Methods: Using a multicenter, retrospective design, this study incorporates data from all patients who underwent an RCR surgical procedure at 1 of 4 academic tertiary health systems across the United States. Data were extracted from Avant-Garde Health’s Care Measurement platform and were analyzed utilizing TDABC methodology. Cost analysis was performed using 2 primary metrics: the opportunity costs arising from a possible reduction in episode duration variability, and the potential monetary savings achievable through the standardization of suture anchor costs. Results: In this study, 921 RCR cases performed at 4 institutions had a mean episode duration cost of $4,094 ± $1,850. There was a significant threefold cost variability between the 10th percentile ($2,282) and the 90th percentile ($6,833) (p < 0.01). The mean episode duration was registered at 7.1 hours. The largest variability in the episode duration was time spent in the post-acute care unit and the ward after the surgical procedure. By reducing the episode duration variability, it was estimated that up to 640 care-hours could be saved annually at a single hospital. Likewise, standardizing suture anchor acquisition costs could generate direct savings totaling $217,440 across the hospitals. Conclusions: This multicenter study offers valuable insights into RCR cost as a function of care pathways and suture anchor cost. It outlines avenues for achieving cost-savings and operational efficiency. These findings can serve as a foundational basis for developing health-economics models. Level of Evidence: Economic and Decision Analysis Level III. See Instructions for Authors for a complete description of levels of evidence.
- 12 September 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (4) , 1120-1129
Revision shoulder arthroplasty: predictors of subsequent revision surgery and economic burden amongst Medicare beneficiaries
- 12 September 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (4) , 1120-1129
Revision shoulder arthroplasty: predictors of subsequent revision surgery and economic burden amongst Medicare beneficiaries
- 1 August 2024
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 12 (8)
Utility of Machine Learning, Natural Language Processing, and Artificial Intelligence in Predicting Hospital Readmissions After Orthopaedic Surgery
Background: Numerous applications and strategies have been utilized to help assess the trends and patterns of readmissions after orthopaedic surgery in an attempt to extrapolate possible risk factors and causative agents. The aim of this work is to systematically summarize the available literature on the extent to which natural language processing, machine learning, and artificial intelligence (AI) can help improve the predictability of hospital readmissions after orthopaedic and spine surgeries.Methods: This is a systematic review and meta-analysis. PubMed, Embase and Google Scholar were searched, up until August 30, 2023, for studies that explore the use of AI, natural language processing, and machine learning tools for the prediction of readmission rates after orthopedic procedures. Data regarding surgery type, patient population, readmission outcomes, advanced models utilized, comparison methods, predictor sets, the inclusion of perioperative predictors, validation method, size of training and testing sample, accuracy, and receiver operating characteristics (C-statistic), among other factors, were extracted and assessed.Results: A total of 26 studies were included in our final dataset. The overall summary C-statistic showed a mean of 0.71 across all models, indicating a reasonable level of predictiveness. A total of 15 articles (57%) were attributed to the spine, making it the most commonly explored orthopaedic field in our study. When comparing accuracy of prediction models between different fields, models predicting readmissions after hip/knee arthroplasty procedures had a higher prediction accuracy (mean C-statistic = 0.79) than spine (mean C-statistic = 0.7) and shoulder (mean C-statistic = 0.67). In addition, models that used single institution data, and those that included intraoperative and/or postoperative outcomes, had a higher mean C-statistic than those utilizing other data sources, and that include only preoperative predictors. According to the Prediction model Risk of Bias Assessment Tool, the majority of the articles in our study had a high risk of bias.Conclusion: AI tools perform reasonably well in predicting readmissions after orthopaedic procedures. Future work should focus on standardizing study methodologies and designs, and improving the data analysis process, in an attempt to produce more reliable and tangible results.Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 August 2024
- Published by Wolters Kluwer Health in JBJS Reviews
- Vol. 12 (8)
Utility of Machine Learning, Natural Language Processing, and Artificial Intelligence in Predicting Hospital Readmissions After Orthopaedic Surgery
Background: Numerous applications and strategies have been utilized to help assess the trends and patterns of readmissions after orthopaedic surgery in an attempt to extrapolate possible risk factors and causative agents. The aim of this work is to systematically summarize the available literature on the extent to which natural language processing, machine learning, and artificial intelligence (AI) can help improve the predictability of hospital readmissions after orthopaedic and spine surgeries.Methods: This is a systematic review and meta-analysis. PubMed, Embase and Google Scholar were searched, up until August 30, 2023, for studies that explore the use of AI, natural language processing, and machine learning tools for the prediction of readmission rates after orthopedic procedures. Data regarding surgery type, patient population, readmission outcomes, advanced models utilized, comparison methods, predictor sets, the inclusion of perioperative predictors, validation method, size of training and testing sample, accuracy, and receiver operating characteristics (C-statistic), among other factors, were extracted and assessed.Results: A total of 26 studies were included in our final dataset. The overall summary C-statistic showed a mean of 0.71 across all models, indicating a reasonable level of predictiveness. A total of 15 articles (57%) were attributed to the spine, making it the most commonly explored orthopaedic field in our study. When comparing accuracy of prediction models between different fields, models predicting readmissions after hip/knee arthroplasty procedures had a higher prediction accuracy (mean C-statistic = 0.79) than spine (mean C-statistic = 0.7) and shoulder (mean C-statistic = 0.67). In addition, models that used single institution data, and those that included intraoperative and/or postoperative outcomes, had a higher mean C-statistic than those utilizing other data sources, and that include only preoperative predictors. According to the Prediction model Risk of Bias Assessment Tool, the majority of the articles in our study had a high risk of bias.Conclusion: AI tools perform reasonably well in predicting readmissions after orthopaedic procedures. Future work should focus on standardizing study methodologies and designs, and improving the data analysis process, in an attempt to produce more reliable and tangible results.Level of Evidence: Level III. See Instructions for Authors for a complete description of levels of evidence.
- 7 June 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (12) , 2637-2645
Racial and gender disparities in utilization of outpatient total shoulder arthroplasties
- 7 June 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (12) , 2637-2645
Racial and gender disparities in utilization of outpatient total shoulder arthroplasties
- 3 June 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (3) , 837-846
A preoperative risk assessment tool for predicting adverse outcomes among total shoulder arthroplasty patients
- 3 June 2024
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 34 (3) , 837-846
A preoperative risk assessment tool for predicting adverse outcomes among total shoulder arthroplasty patients
- Open Access
- 1 April 2024
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 9 (2)
Five-Year Mortality Rates Following Elective Shoulder Arthroplasty and Shoulder Arthroplasty for Fracture in Patients Over Age 65
Background: To effectively counsel patients prior to shoulder arthroplasty, surgeons should understand the overall life trajectory and life expectancy of patients in the context of the patient’s shoulder pathology and medical comorbidities. Such an understanding can influence both operative and nonoperative decision-making and implant choices. This study evaluated 5-year mortality following shoulder arthroplasty in patients ≥65 years old and identified associated risk factors. Methods: We utilized Centers for Medicare & Medicaid Services Fee-for-Service inpatient and outpatient claims data to investigate the 5-year mortality rate following shoulder arthroplasty procedures performed from 2014 to 2016. The impact of patient demographics, including fracture diagnosis, year fixed effects, and state fixed effects; patient comorbidities; and hospital-level characteristics on 5-year mortality rates were assessed with use of a Cox proportional hazards regression model. A p value of <0.05 was considered significant. Results: A total of 108,667 shoulder arthroplasty cases (96,104 nonfracture and 12,563 fracture) were examined. The cohort was 62.7% female and 5.8% non-White and had a mean age at surgery of 74.3 years. The mean 5-year mortality rate was 16.6% across all shoulder arthroplasty cases, 14.9% for nonfracture cases, and 29.9% for fracture cases. The trend toward higher mortality in the fracture group compared with the nonfracture group was sustained throughout the 5-year postoperative period, with a fracture diagnosis being associated with a hazard ratio of 1.63 for mortality (p < 0.001). Medical comorbidities were associated with an increased risk of mortality, with liver disease bearing the highest hazard ratio (3.07; p < 0.001), followed by chronic kidney disease (2.59; p < 0.001), chronic obstructive pulmonary disease (1.92; p < 0.001), and congestive heart failure (1.90; p < 0.001). Conclusions: The mean 5-year mortality following shoulder arthroplasty was 16.6%. Patients with a fracture diagnosis had a significantly higher 5-year mortality risk (29.9%) than those with a nonfracture diagnosis (14.9%). Medical comorbidities had the greatest impact on mortality risk, with chronic liver and kidney disease being the most noteworthy. This novel longer-term data can help with patient education and risk stratification prior to undergoing shoulder replacement. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 1 April 2024
- Published by Wolters Kluwer Health in JBJS Open Access
- Vol. 9 (2)
Open AccessFive-Year Mortality Rates Following Elective Shoulder Arthroplasty and Shoulder Arthroplasty for Fracture in Patients Over Age 65
Background: To effectively counsel patients prior to shoulder arthroplasty, surgeons should understand the overall life trajectory and life expectancy of patients in the context of the patient’s shoulder pathology and medical comorbidities. Such an understanding can influence both operative and nonoperative decision-making and implant choices. This study evaluated 5-year mortality following shoulder arthroplasty in patients ≥65 years old and identified associated risk factors. Methods: We utilized Centers for Medicare & Medicaid Services Fee-for-Service inpatient and outpatient claims data to investigate the 5-year mortality rate following shoulder arthroplasty procedures performed from 2014 to 2016. The impact of patient demographics, including fracture diagnosis, year fixed effects, and state fixed effects; patient comorbidities; and hospital-level characteristics on 5-year mortality rates were assessed with use of a Cox proportional hazards regression model. A p value of <0.05 was considered significant. Results: A total of 108,667 shoulder arthroplasty cases (96,104 nonfracture and 12,563 fracture) were examined. The cohort was 62.7% female and 5.8% non-White and had a mean age at surgery of 74.3 years. The mean 5-year mortality rate was 16.6% across all shoulder arthroplasty cases, 14.9% for nonfracture cases, and 29.9% for fracture cases. The trend toward higher mortality in the fracture group compared with the nonfracture group was sustained throughout the 5-year postoperative period, with a fracture diagnosis being associated with a hazard ratio of 1.63 for mortality (p < 0.001). Medical comorbidities were associated with an increased risk of mortality, with liver disease bearing the highest hazard ratio (3.07; p < 0.001), followed by chronic kidney disease (2.59; p < 0.001), chronic obstructive pulmonary disease (1.92; p < 0.001), and congestive heart failure (1.90; p < 0.001). Conclusions: The mean 5-year mortality following shoulder arthroplasty was 16.6%. Patients with a fracture diagnosis had a significantly higher 5-year mortality risk (29.9%) than those with a nonfracture diagnosis (14.9%). Medical comorbidities had the greatest impact on mortality risk, with chronic liver and kidney disease being the most noteworthy. This novel longer-term data can help with patient education and risk stratification prior to undergoing shoulder replacement. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
- 23 August 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (4) , 841-849
Trends and outcomes of outpatient total shoulder arthroplasty after its removal from CMS's inpatient-only list
- 23 August 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (4) , 841-849
Trends and outcomes of outpatient total shoulder arthroplasty after its removal from CMS's inpatient-only list